Eli Lilly and Co. is startled, novo-nordisk a/s saves the day! The market prospects for weight loss drugs still tempt many players.
The weight loss drug market still has a broad prospect, with most institutions predicting that the market size will reach the trillion-dollar level by the end of this decade.
Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
Express News | Amgen Exec Says Some Supplemental Maritide Data Published Were Not Subject to Our Standard Institutional Review,
Express News | Amgen Exec Says Believe That a Research Note Had Suggested "an Inappropriate Inference" of Maritide Data Given Its Limitations
Express News | Amgen Exec Says Co Has Not Seen Any Association Between Administration of Maritide and Bone Mineral Density Changes or Safety Signals for Bone